Broad Institute

Responding to COVID19

Learn how the Broad community is contributing to the global pandemic response

Promoting inclusion

Broad Institute believes that progress in biomedical research requires a fully inclusive community across sex, race, ethnicity, sexual orientation, age, and gender identity

Sharing data and knowledge

Broad Institute is committed to making the extensive data, methods, and technologies it generates rapidly and readily accessible to the scientific community to drive biomedical progress around the world

Building partnerships

Broad Institute works to build and sustain international consortia to speed discovery in areas including psychiatric research, infectious disease, cardiovascular disease, and cancer

Empowering scientists

Broad Institute fosters an environment in which scientists can take risks on bold ideas with transformative potential

Reaching globally

Broad Institute is committed to addressing medical challenges across the world, including collaborating with scientists and public health experts to address important needs in developing countries

Collaborating deeply

Broad Institute is a mission-driven community that brings together researchers in medicine, biology, chemistry, computation, engineering, and mathematics from across MIT, Harvard, and Harvard-affiliated hospitals, along with collaborators around the world

Propelling the understanding and treatment of disease

Broad Institute of MIT and Harvard is empowering a revolution in biomedicine to accelerate the pace at which the world conquers disease

INSIDE BROAD

News / 07.10.20

Broad Institute launches academic-industry cell imaging consortium to speed drug discovery and development

The Joint Undertaking in Morphological Profiling with Cell Painting aims to accelerate drug discovery and development by creating a massive dataset of cells imaged under more than 140,000 different conditionsRead more

News / 07.8.20

New molecular tool precisely edits mitochondrial DNA

An engineered bacterial toxin is a key part of a gene editor that can make single-base changes in human mitochondria.Read more

News / 07.8.20

International Common Disease Alliance releases action plan to drive next phase of genetic understanding of common disease

Report defines priorities, proposes international collaborations to accelerate progress from genetic maps to biological mechanisms to medical treatmentsRead more

News / 07.9.20

Lung cancer proteome builds on genetic findings to reveal therapeutic strategies

International collaboration uncovers biological impacts of common cancer mutations, highlights key features of smoking- and nonsmoking-related lung cancersRead more

News / 06.24.20

“Genetic trades” of more than 50 gene variants are linked to common blood disorder

Study reveals surprising genomic swapping that underlies clonal hematopoiesis, a condition that can lead to blood cancer and heart disease.Read more

News / 07.10.20

Research Roundup: July 10, 2020

First-ever mitochondrial DNA editor, social factors and COVID-19, a gene drive tuner, and moreRead more

News / 06.17.20

New machine learning tool predicts base editing outcomes

BE-Hive can tell which base editor performs best to repair thousands of disease-causing mutationsRead more

News / 06.18.20

Fei Chen named as a core member of Broad Institute

A former Schmidt fellow, Chen uses microscopy and spatial genomics to learn about cells and study biological processesRead more

News / 06.15.20

Cholesterol-busting gut bacteria may affect people’s cardiac health

Researchers have discovered bacteria that break down cholesterol in the gut, potentially lowering blood cholesterol levels.Read more

Blog / 06.4.20

Introduction and spread of SARS-CoV-2 in the greater Boston area

New data from the Broad Institute of MIT and Harvard, Massachusetts General Hospital, and the Massachusetts Department of Public Health provides insights into the entry of SARS-CoV-2 virus in the Boston area, and epidemiological events that shaped the trajectory of the epidemic in the region.Read more